Skip to main content

Research Repository

Advanced Search

MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness

People Involved

Julie Seymour

Elizabeth Wilson

Dawn Wood

Judith Long

Bronwen Williams

Kathryn Date

Kerri Morris

Project Description

A parallel group, double-blind, randomised placebo-controlled trial comparing the efficacy and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of breathlessness and daily activity in people with chronic breathlessness.

Status Project Live
Funder(s) National Institute for Health Research
Value £731,274.00
Project Dates Mar 1, 2019 - Feb 29, 2024

You might also like

TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Dec 31, 2026
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe... Read More about TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research.

Feb 27, 2017 - Sep 30, 2018